AMA Update

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.

AMA Update is your source for physician-focused news. Hear from physicians and other experts on trending public health concerns, practice issues, and more. Because who’s doing the talking matters.


All Episodes

AMA Update 97: Andrea Garcia, JD, MPH, discusses recent EUA for Pfizer’s COVID vaccine for 5-11 year olds

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA’s authorization of Pfizer-BioNTech’s coronavirus vaccine for emergency use in children 5 to 11, vaccine mandates in schools, and the AMA’s support of the Biden Administration’s plan to address the nation’s overdose epidemic.

AMA Update 96: Dr. Aaron Carroll talks Halloween and holidays and how to assess risk

AMA CXO Todd Unger discusses Halloween and assessing risk heading into the holiday season with Dr. Aaron Carroll, a professor of pediatrics and chief health officer at Indiana University. 

AMA Update 95: Andrea Garcia, JD, MPH, discusses vaccine authorization for 5-11 year olds

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster news and current vaccine timeline for the 5 to 11 year old age group.

AMA Update 94: Dr. Sandra Fryhofer shares the latest on boosters and the new «mix-and-match strategy»

AMA CXO Todd Unger discusses what physicians need to know about boosters for Moderna, J&J recipients, and the newly approved mix-and-match strategy, with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

AMA Update 93: Andrea Garcia, JD, MPH, discusses boosters and pending authorizations

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering booster shots (including FDA and CDC recommendations), COVID case spikes related to dropping temperatures, and a reminder to get your annual flu shot.

AMA Update 92: CDC’s Dr. Alex Kallen discusses what physicians need to know about infection prevention and control

AMA CXO Todd Unger talks with the CDC’s Dr. Alex Kallen, chief of the Prevention and Response Branch in the Division of Healthcare Quality Promotion, about the importance of infection prevention and control and what physicians need to know about updated guidance in this area.  

AMA Update 91: Andrea Garcia, JD, MPH, discusses EUA requests for boosters and children ages 5-11

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID-19 vaccine emergency use authorization (EUA) requests from Pfizer for children ages 5-11, as well as movement on boosters for Johnson & Johnson and Moderna vaccine recipients.

AMA Update 90: Baptist Health leadership on combating rising COVID cases in south Florida

AMA CXO Todd Unger discusses navigating the resurgence of COVID cases in southern Florida with Dr. Bernie Fernandez, the CEO of Baptist Health Medical Group, and Bill Ulbricht the Chief Operating and Administrative Officer for the Clinical Enterprise division of Baptist Health South Florida.

AMA Update 89: Andrea Garcia, JD, MPH, discusses trends and urgent call for pregnant people to get vaccinated

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering movement on FDA’s J&J and Moderna booster EUA consideration, New York’s vaccine mandate, and Merck’s antiviral COVID-19 treatment pill.